(19)
(11) EP 1 041 986 A1

(12)

(43) Date of publication:
11.10.2000 Bulletin 2000/41

(21) Application number: 98953372.4

(22) Date of filing: 09.10.1998
(51) International Patent Classification (IPC)7A61K 31/47, A61K 31/155, C07C 215/14, C07D 215/14
(86) International application number:
PCT/US9821/395
(87) International publication number:
WO 9918/962 (22.04.1999 Gazette 1999/16)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 10.10.1997 US 63469 P

(71) Applicant: CAMBRIDGE NEUROSCIENCE, INC.
Cambridge, MA 02139 (US)

(72) Inventors:
  • DURANT, Graham, J.
    Wellesley, MA 02181 (US)
  • PERLMAN, Michael
    Brookline, MA 02146 (US)
  • FISCHER, James, B.
    Cambridge, MA 02139 (US)
  • PADMANABHAN, Seetharamaiyer
    Malden, MA 02148 (US)

(74) Representative: Plougmann, Vingtoft & Partners A/S 
Sankt Annae Plads 11,P.O. Box 3007
1021 Copenhagen K
1021 Copenhagen K (DK)

   


(54) PHARMACEUTICALLY ACTIVE COMPOUND AND METHODS OF USE